论文期刊

取消

高级检索

检索历史清除

首页> Thyroid: official journal of the American Thyroid Association> The PLK1 inhibitor GSK461364A Is effective in poorly differentiated and anaplastic thyroid carcinoma cells, independent of the nature of their driver mutations

The PLK1 inhibitor GSK461364A Is effective in poorly differentiated and anaplastic thyroid carcinoma cells, independent of the nature of their driver mutations

导出原文传递

翻译打印收藏纠错

作者： Russo,M.A. ^[1] ; Kang,K.S. ; DiCristofano,A.

作者单位： Department of Developmental and Molecular Biology, Price Center for Genetic and Translational ^[1]

发布时间 2014-03-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

1284-1293页

1284-1293页

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

官方微信

万方医学小程序

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序